I want to introduce a great company to you, Nutra Pharma Corporation (OTCQB: NPHC).
Likely you saw last week where Global Small Caps initiated coverage on NPHC with a target of $0.10. While StockGuru never issues price targets, I don’t want to keep you in the dark when it comes to other coverage of Nutra Pharma Corp. See that report HERE. So far, the stock has not moved in that direction.
Other Recent News Coverage of Nutra Pharma Corp:
This is from NBC News in Miami.
Nyloxin is already available on the market. From the Nyloxin website, “Nyloxin provides all-natural, anti-inflammatory, analgesic pain relief that is non-toxic, non-narcotic, non-addictive, non-steroidal and does not contain aspirin or acetaminophen.”
If you’ve ever had a pet in pain, you need to learn about Pet Pain-Away. It is a remarkable new product from NPHC.
Here’s a video that tells the story:
Here’s more details from the Pet Pain-Away website:
Pet Pain Away provides all-natural anti-inflammatory analgesic pain relief that is non-toxic, non-narcotic, non-steroidal and contains no aspirin or acetaminophen. Safe to use on pets. It treats conditions that cause chronic pain in animals.
Pet Pain Away is 100% Safe to Treat Your Pet’s Pain
Pet Pain Away works by targeting receptors on nerve cells. These receptors are found in nerves outside of the central nervous system (brain and spinal cord) and they are also found on cells of the immune system. Specialized proteins in Pet Pain Away block the action of acetylcholine, a major stimulating neurotransmitter in the nervous system and activator of the inflammatory pathways. As a result, the pain and inflammation pathways are temporarily shut off. In clinical studies, the pain relieving ingredients in Pet Pain Away provided prolonged chronic muscle and joint relief.
We have much more coming this week!
NPHC Disclosure: We hold not shares and will not be receiving any shares. This means that as we release new information about a particular client company either on our site or otherwise authored by us, you can be confident we don’t own shares, will not be buying shares and will not be selling shares. StockGuru makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. We expect to be compensated up to five thousand seven hundred dollars for coverage, assuming three months coverage. StockGuru – McKinney, Texas 75070 – (469) 358-5200.